AFP and hepatocellular carcinoma: Taken together, these findings suggest that AFP is a potential HCC therapeutic target and that screening novel reagents or identifying potential measures to disrupt cytoplasmic AFP will produce direct benefits for the treatment of advanced HCC displaying AFP overexpression.